Promoting Adherence to Treatment in Schizophrenia

NCT ID: NCT01125267

Last Updated: 2010-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

174 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-04-30

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project evaluates a culturally adapted, family-based intervention designed to promote treatment adherence among Mexican-Americans with schizophrenia using a randomized, controlled design in a public mental health setting. Mexican-American patients with schizophrenia and their families were randomly assigned to either: 1) one year of multi- family groups that emphasize the importance of attitudes towards adherence, subjective norms, and self-perceived and actual adherence skills in maintaining adherence, added to ongoing customary outpatient care; 2) standard multi-family groups without an emphasis on medication adherence, added to customary outpatient care; or 3) customary outpatient care only (monthly pharmacotherapy sessions and additional services as clinically needed). The study hypotheses are that subjects assigned to the adapted multi-family group would have better medication adherence, less psychiatric symptoms and fewer psychiatric hospitalizations throughout the course of the study (one year of treatment and one year of follow up) compared to the comparison conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As above

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

multifamily group-adherence

multifamily group treatment with a focus on improving adherence to antipsychotic medication

Group Type EXPERIMENTAL

multifamily group-adherence

Intervention Type BEHAVIORAL

multifamily groups held twice a month for one year focused on improving medication adherence using techniques derived from the Theory of Planned Behavior

multifamily group-standard

multifamily group focused on problems identified by group participants

Group Type ACTIVE_COMPARATOR

multifamily group-standard

Intervention Type BEHAVIORAL

multifamily groups held twice a month focused on general problem solving method

treatment as usual

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multifamily group-adherence

multifamily groups held twice a month for one year focused on improving medication adherence using techniques derived from the Theory of Planned Behavior

Intervention Type BEHAVIORAL

multifamily group-standard

multifamily groups held twice a month focused on general problem solving method

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DSM-IV diagnosis of schizophrenia or schizoaffective disorder;
* Between 18 and 50 years of age;
* Of Mexican origin and speaks Spanish fluently;
* Was without antipsychotic medication without medical authorization for one continuous week in the month prior to hospitalization;
* Was living with his/her family of origin immediately preceding the inpatient stay and would return to live with his/her family after discharge; and
* The patient and at least one family member were willing to participate.

Exclusion Criteria

* Patient on conservatorship or legal guardian status
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of California, Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Geffen School of Medicine at UCLA

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alex J Kopelowicz, MD

Role: PRINCIPAL_INVESTIGATOR

Geffen School of Medicine at UCLA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

San Fernando Mental Health Center

Granada Hills, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Kopelowicz A, Zarate R, Wallace CJ, Liberman RP, Lopez SR, Mintz J. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia. Arch Gen Psychiatry. 2012 Mar;69(3):265-73. doi: 10.1001/archgenpsychiatry.2011.135.

Reference Type DERIVED
PMID: 22393219 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R01MH064542-05

Identifier Type: NIH

Identifier Source: secondary_id

View Link

5R01MH064542-05

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile CBT for Negative Symptoms
NCT03621774 COMPLETED NA